Quality Control in Pharma: Essential Tests and GMP Practices in 2026

Quality Control (QC) in the pharmaceutical industry is a systematic process that ensures drug products meet established standards for safety, efficacy, and quality. A 2017 WHO study estimated that 1 in 10 medical products circulating in low- and middle-income countries is substandard or falsified, based on more than 48,000 medicine samples from 88 countries. That figure shows why reliable QC testing matters at every stage of the supply chain.

Effective QC helps manufacturers comply with regulatory requirements while protecting patient health by preventing defective or unsafe medicines from reaching the market.

Good Manufacturing Practices (GMP) provide the comprehensive framework supporting Quality Control activities.

Under EU GMP, Quality Control covers sampling, specifications, testing, documentation, and release procedures, and no material or product may be released until its quality has been judged satisfactory. Adhering to GMP not only strengthens QC but also improves overall product consistency, ensuring that pharmaceutical companies deliver safe and effective medicines worldwide.

Table of Contents

What is Quality Control (QC) in pharma?

In practice, QC is the GMP function that decides whether components, containers and closures, in-process materials, and finished products meet their approved specifications. It is not limited to the laboratory, however. EU GMP expects QC to take part in all decisions that may affect product quality and to stay independent from Production.

QC includes several key activities such as: 

  • Testing drug purity and potency
  • Checking packaging integrity
  • Recording test results accurately
  • Investigating deviations or failures
  • Reporting findings to quality teams

Together, these steps ensure safe, effective medicines for patients.

Importance of Quality Control in pharmaceutical manufacturing

Quality Control plays a vital role in pharmaceutical manufacturing by ensuring product safety and effectiveness. It detects errors early, reducing costly recalls and health risks. For example, US CGMP rules require finished drug products that fail their specifications to be rejected, so a reliable QC result directly protects patients from receiving a defective batch.

Furthermore, QC helps companies meet strict regulatory requirements globally, boosting patient trust and market access.

In addition, effective Quality Control protects companies from financial losses and legal issues. It improves manufacturing efficiency by identifying process weaknesses quickly. Therefore, investing in QC systems strengthens overall production and safeguards public health.

Key Quality Control processes and procedures in pharma

Pharma companies follow key Quality Control processes to ensure product safety and quality. First, they perform careful sampling and sample preparation. Then, they use accurate analytical testing methods. These steps help detect defects and ensure consistency. Also, companies keep detailed documentation and records to track quality data and support audits.

Additionally, deviation handling and reporting play a crucial role in QC. Staff identify and report any quality issues quickly. They investigate problems and take corrective actions. Thus, these processes maintain high standards and comply with regulations. 

Key QC processes include: 

  • Sampling and Sample Preparation

     

  • Analytical Testing Methods

     

  • Documentation and Record Keeping

     

  • Deviation Handling and Reporting

Number 1 Sampling and Sample Preparation

Sampling decides whether a test result says anything useful about the batch. Under EU GMP, samples should be representative of the batch they come from, and the sampling plan should be justified with a risk management approach. Extra samples may also be taken from the most stressed part of a process, such as the beginning or end of a run.

Every sample should be taken and recorded under an approved written procedure. That procedure defines the sampling method, the equipment, the sample amount, any sub-division of the sample, the container type, the identification of sampled containers, special precautions for sterile or hazardous materials, storage conditions, and the cleaning of sampling tools. Each sample container should show the contents, batch number, sampling date, and the containers sampled, which prevents mix-ups in the laboratory.

You can download the FDA Guide Analytical Procedures and Methods Validation for Drugs and Biologics here

Pharma QC Sampling Workflow
Pharma QC Sampling Workflow

Number 2 Analytical Testing Methods

Analytical testing methods help pharma companies check drug quality and safety. They use tests like chromatography and spectroscopy to identify ingredients and impurities. Also, these methods ensure products meet standards and regulatory rules. Companies choose tests based on the drug type and required accuracy.

Key analytical testing methods include: 

  • Chromatography for separating mixtures
  • Spectroscopy (UV, IR) for identity and content testing
  • Titration for concentration analysis
  • Microbial testing for contamination detection

 

The FDA guidance “Analytical Procedures and Methods Validation for Drugs and Biologics” explains how companies should validate these methods. In addition, ICH Q2(R2), adopted in November 2023, replaced Q2(R1) and describes how to show that an analytical procedure is fit for its intended purpose.

Number 3 Documentation and Record Keeping

Documentation and record keeping help maintain transparency and traceability in Quality Control (QC). Companies record test results, procedures, and equipment details to track quality over time. Also, they update documents regularly to prevent errors and ensure compliance with regulations.

For example, a test report logs sample data and results. Similarly, a calibration record tracks instrument accuracy and maintenance.

Number 4 Deviation Handling and Reporting

Deviation handling helps companies identify and fix problems during production or testing. Workers report deviations quickly and investigate root causes to prevent repeats. Also, they document actions taken to maintain product quality and meet regulations.

 

For example, a missed temperature check triggers a deviation report. Similarly, an unexpected test result leads to a detailed investigation.

Common Quality Control tests for pharmaceutical products

Quality Control tests check pharmaceutical products to ensure they are safe and effective. These tests measure physical, chemical, and microbiological properties. Also, they help detect any defects or contamination before products reach patients.

 

Common tests include: 

  • Physical tests like hardness, friability, and dissolution
  • Chemical tests such as assay, impurity profiling, and content uniformity
  • Microbiological tests including sterility, microbial limits, and endotoxin testing

Physical Tests (e.g., hardness, friability, dissolution)

Physical tests help ensure tablets and capsules have the right strength and quality. These tests check how products behave during handling and use. Also, they identify issues that affect medicine performance.

Common physical tests include: 

  • Hardness measures tablet strength under pressure
  • Friability tests tablet resistance to breaking
  • Dissolution checks medicine release rate
  • Thickness measures tablet size
  • Weight variation checks consistency
  • Disintegration tests tablet breaking time

For injectable products, QC also depends on visual inspection of filled units for visible particles and container defects.

Chemical Tests (e.g., assay, impurity profiling, content uniformity)

Chemical tests check the medicine’s ingredients and purity. They ensure the correct amount of active substance exists. Also, these tests find harmful impurities that affect safety.

 

Key chemical tests include assay, impurity profiling, content uniformity, and pH measurement. These tests help maintain medicine quality and patient safety at all times.

Common Chemical Tests & Parameters

Test Parameter Measured Purpose Method Used
Assay
Active ingredient content
Confirm correct dosage
HPLC, GC, LC-MS
Impurity Profiling
Impurity types and levels
Detect harmful substances
GC, LC-MS
Content Uniformity
Dosage consistency
Ensure uniform medicine dose
HPLC or UV Spectroscopy
pH Measurement
Acidity or alkalinity
Confirm pH meets the specification
pH Meter

Microbiological Tests (e.g., sterility, microbial limits, endotoxin testing)

Microbiological tests help ensure products stay safe and clean. They check for bacteria, fungi, and toxins that may harm users. For example, sterility tests verify no live microbes exist. Additionally, microbial limits tests confirm the microbes stay within safe levels. Endotoxin tests detect harmful bacterial toxins quickly.

In pharma, the test plan depends on the dosage form: sterile products need sterility testing, parenteral products are usually also tested for bacterial endotoxins, and non-sterile products are checked against microbial limits. They also prevent contamination during production and storage. Companies use different methods to keep products safe and effective. Key microbiological tests include:

  • Sterility testing to ensure no viable microorganisms exist
  • Microbial limit testing to check total microbial count
  • Endotoxin testing to detect harmful bacterial toxins
  • Total yeast and mould count (TYMC) as part of microbial limit testing

Microbiological Test Types & Purposes

Test Type Purpose Sample Tested Common Method Used
Total Aerobic Microbial Count (TAMC)
Determine total microbial load
Raw materials, products
Plate Count Method
Sterility Test
Confirm absence of microorganisms
Sterile products
Membrane filtration or direct inoculation
Microbial Limit Test
Ensure microbes within limits
Non-sterile products
Plate Count, MPN
Endotoxin Test
Detect bacterial endotoxins
Injectable products
LAL Assay

How to implement Quality Control systems in pharma

To implement quality control systems in pharma, start by training staff clearly. Next, establish standard procedures for every production step. Also, monitor processes constantly to catch problems early. Moreover, document all actions carefully to ensure full traceability and compliance.

Focus areas include:

  • Write approved specifications and test procedures for every material and product
  • Qualify and calibrate laboratory instruments on a defined schedule
  • Record critical results in a way that allows trend analysis
  • Keep a written procedure for out-of-specification and out-of-trend results
Steps to Implement Pharma QC Systems
Steps to Implement Pharma QC Systems

How QC Supports Batch Release and Stability Monitoring

QC results feed directly into the batch release decision. Under EU GMP, finished product assessment goes beyond the final test report. It also considers production conditions, in-process test results, a review of manufacturing and packaging records, compliance with the finished product specification, and an examination of the final pack.

Therefore, every test record should let a reviewer reconstruct the work. At a minimum, it shows the product name and dosage form, the batch number, the specification and test procedure used, the results with observations and calculations, the testing dates, who performed and checked the work, the equipment used, and a clear approval or rejection decision signed by the responsible person.

QC work also continues after release. An on-going stability programme monitors the marketed product over its shelf life and confirms that it stays within specification under the labelled storage conditions. Unless otherwise justified, at least one batch per year of each strength and primary packaging type should enter the programme. Confirmed out-of-specification results or significant negative trends affecting released batches should be reported to the competent authorities.

What Happens When a QC Result Is Out of Specification

An out-of-specification (OOS) result is any test result that falls outside the specifications or acceptance criteria set in a drug application, a drug master file, an official compendium, or by the manufacturer. US CGMP rules require an OOS investigation whenever such a result appears, and the investigation must be documented with its conclusions and follow-up. Even if the batch is rejected, the investigation is still needed to check whether other batches are affected.

FDA guidance splits this work into two phases. In Phase I, the analyst and supervisor review the method, raw data, calculations, instrument performance, and reference standards, ideally before test preparations are discarded. If no clear laboratory error is found, Phase II becomes a full-scale investigation led by the quality unit, including a review of production and sampling. Repeated testing until a passing result appears is called “testing into compliance,” and FDA considers it objectionable.

An OOS result requires a documented Phase I laboratory assessment, followed by Phase II investigation when necessary, before a science-based batch disposition decision.
Steps to Implement Pharma QC Systems

Final Word

Quality control in pharma works only when every step holds up: representative sampling, validated methods, complete records, and honest investigation of unexpected results. Strong QC does more than catch defective batches. It also produces the trend data that helps teams fix weak processes before they fail. For anyone working in or moving into a QC laboratory, the core habits stay the same: know your specifications, rely on validated methods, and document every result, including the ones you would prefer not to see.

Regulatory bodies, including the FDA, demand thorough root cause analyses and corrective actions to ensure drug safety. Ignoring OOS issues risks regulatory sanctions or product recalls, which can damage public trust and restrict market access.

In conclusion, minimizing OOS incidents is vital for pharmaceutical quality and patient safety. Adhering to Good Manufacturing Practices (GMP) reduces OOS rates by up to 35%, according to WHO estimates. Companies should invest in training, strong quality controls, and robust investigations to maintain compliance. For further data, sources like IQVIA Institute reports, FDA Market Data Dashboards, and WHO Global Market Analysis provide valuable insights. Addressing OOS proactively supports continuous improvement and regulatory success.

FAQs

1️⃣ Is quality control the same as quality assurance in pharma?

 

No. QC samples and tests materials and products against approved specifications and decides whether they conform. QA is the broader system that controls procedures, deviations, changes, and release across the product lifecycle. QC is one part of that quality system, and GMP requires both.

2️⃣ Can a QC laboratory retest a sample until it passes?

 

No. FDA calls this practice “testing into compliance” and treats it as objectionable under CGMP. Retesting is allowed only as part of an OOS investigation, and the maximum number of retests should be fixed in advance in a written SOP.

3️⃣ What are some common QC tests performed in pharma?

 

Common tests include physical (hardness, dissolution), chemical (assay, impurity profiling), and microbiological (sterility, endotoxin) tests.

Picture of Ershad Moradi

Ershad Moradi

Ershad Moradi, a Content Marketing Specialist at Zamann Pharma Support, brings 6 years of experience in the pharmaceutical industry. Specializing in pharmaceutical and medical technologies, Ershad is currently focused on expanding his knowledge in marketing and improving communication in the field. Outside of work, Ershad enjoys reading and attending industry related networks to stay up-to-date on the latest advancements. With a passion for continuous learning and growth, Ershad is always looking for new opportunities to enhance his skills and contribute to pharmaceutical industry. Connect with Ershad on Facebook for more information.

Share